Latest News
Latest Event
Cancer AI Symposium
Latest Financial Results
Q2 2024
Quarter Ended Jun 30, 2024
Latest Annual Filing
For Fiscal Year Ending Dec 31, 2023
Report Links
Email Alerts
Sign up today and receive company updates straight to your inbox.
Company Overview
BullFrog AI, an emerging digital biopharma company, is committed to changing that paradigm.
Using our proprietary AI/ML analytics platform, we aim to improve drug development and clinical trials through identification of high-value data niches and patient subgroups. This will ultimately lead to improved clinical outcomes for patients, and reduction of trial-and-error treatment strategies in our disease areas of focus.
Our mission is to improve lives by identifying critical connections between therapies and highly responsive patients – in less time, with less cost, and more precision.
IR Contacts
Headquarters
BullFrog AI Holdings, Inc.
325 Ellington Blvd.
#317
Gaithesburg, MD 20878
T: 240-658-6710
info@bullfrogai.com
Investor Relations
RedChip Companies Inc.
Rob Foley
VP Investor Relations
431 E Horatio Ave
Suite #100
Maitland, FL 32751
T: 1-800-RED-CHIP (733-2447)
Rob@redchip.com
Transfer Agent
VStock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
T: 212-828-8436
F: 646-536-3179
0-K@vstocktransfer.com